Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Recce antibiotic equal to or better than commercial antibiotic at killing superbugs

January 15, 2016 By MDO Editor

Chart1Recce is pleased to announce that in a test of efficacy, conducted in an independent and approved contract laboratory in the United States, RECCE antibiotic (at lower concentration) performed equally (in terms of number of surviving mice) or better (in terms of Health Score of the surviving mice) than a commercial antibiotic (chosen as it is a remaining antibiotic having efficacy against the superbug, Methicillin Resistant Staphylococcus aureus [MRSA]).

This confirms a comparable result in which RECCE antibiotic performed better, and reported in Appendix 3, page 39 of the Replacement Prospectus of 21 Sept. 2015.

In the test reported today, three groups of 10 mice were each infected with MSRA superbug:

  • six mice treated with RECCE antibiotic survived
  • six mice treated with commercial antibiotic (Oxacillin) survived
  • four mice that had no treatment, only saline, survived

Chart2The test compared RECCE antibiotic at 132 mg/Kg of mouse—with the commercial antibiotic Oxacillin, the positive control antibiotic at a larger dose of 500 mg/Kg and saline negative control, over 8 days. The survival rates (after culling) of mice within the three groups, each of 10 mice, respectively—after infection with MRSA superbug, is shown.

Further, in the test reported, in terms of Health Score of the remaining (non-culled) mice, the RECCE antibiotic left more healthy mice.

The health of remaining mice was qualitatively assessed according to their appearance and behavior. Mice having a Health Score of 1 are rated healthy; those having a Health Score of 4 are rated unhealthy.

Recce
recce.com.au

Related Articles Read More >

Myoshirt creator Marie Georgarakis wearing her device, which has cufs on her arm supported by a cable connected to equipment on her shoulder.
Researchers develop wearable robotic exomuscle system
Clippard NIV Series media isolation valves
Clippard releases new series of isolation valves
A cylindrical-shaped medical device with a blue cap on one end and a brown cap on the other
How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
Northwestern University dissolvable pacemaker
This smart, dissolving pacemaker communicates with sensors on the body for remote patient monitoring

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech